OptumRx is calling on pharmaceutical companies to deploy major changes toward rebates, according to a STAT report, but appears to be looking after its own bottom line. The pharmacy benefit manager in December sent a letter to companies demanding seven-quarters notice before lowering drug prices, […]
PBMs Defend Against Trump Administration’s Proposal
The Pharmaceutical Care Management Association (PCMA) is fighting back against claims that pharmacy benefit managers are to blame for rising drug prices, FierceHealthcare reports, and has launched a new initiative aimed at educating consumers. The campaign, #OnYourRxSide, comes on the heels of the […]
Report: PhRMA Could Accept Inflation Limits
The Pharmaceutical Research and Manufacturers of America (PhRMA) board is mulling a proposal that would commit members to cap price hikes for drugs purchased by Medicare, according to a BioCentury report. According to the report, which cites unnamed biopharmaceutical executives familiar with the […]
Report: Cummings Seeks 10 Years of Pricing Data from Pharma
Democratic Rep. Elijah Cummings is looking for 10 years worth of pricing and research data from the 12 pharmaceutical companies being investigated by the House Oversight Committee, STAT reports. The first hearing on the investigation is scheduled for Jan. 29. Cummings tells STAT that the probe […]
Cummings: Current Rate of Price Increases ‘Unsustainable’
U.S. House Oversight Committee Chairman Elijah Cummings says research and development by major pharmaceutical companies has paved the way for "groundbreaking medications," but called the current rate of price increases "unsustainable," according to an Associated Press report. Cummings, a Democrat, […]
J&J Raises Prices after CEO Tells Pharma to Watch Price Hikes
Days after Johnson & Johnson CEO Alex Gorsky urged the pharmaceutical industry to better police itself on price increases, the drugmaker hiked list prices on a number of drugs in its portfolio, including Xarelto, Stelara and Zytiga, FiercePharma reports. According to the report, a majority of […]
Top Pharma Trends Going into 2019
Eyeforpharma in a recent article breaks down what it says are the top trends in the pharmaceutical sector as we kick off the new year. Its No. 1 top trend involves drug pricing and the affordability of health care amid concerns about how consumers are handling the high costs. "I foresee further […]
PhRMA: 10 Key Facts About Drug Spending, Costs
PhRMA in a recent Catalyst post offers a brief look at 10 facts it says you should know about drug spending and costs. In the post, PhRMA points to chronic disease as a main driver of health care costs, adding that medicine is the "country's best chance" at combating high costs. "Health […]
Drugmakers Raise Prices to Start 2019
A number of pharmaceutical companies raised prices on hundreds of drugs to ring in the new year, according to a MarketWatch report.Allergan PLC is reportedly leading the increases with a roughly 10 percent hike on more than two dozen drugs. The drugmaker said it increased prices on 51 of its […]
Report: Pharma Price Hikes Fewer, Smaller at Beginning of 2018c5rrrr
Increasing pressure on drugmakers to ease their drug pricing strategies has led a not only less-frequent price hikes, but also less significant increases, according to a Leerink analysis. According to an Endpoint News report, the analysis included 17 biopharmaceutical companies, including AbbVie, […]
